학술논문

Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas.
Document Type
Article
Source
One Health Outlook; 6/24/2022, Vol. 4 Issue 1, p1-5, 5p
Subject
MIDDLE East respiratory syndrome
BINDING site assay
THERAPEUTIC use of immunoglobulins
RESERVOIRS
IMMUNIZATION
Language
Abstract
Copyright of One Health Outlook is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Online Access